Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05617716 · ClinicalTrials.gov registry record · Phase 2
Spine Radiosurgery for Symptomatic Metastatic Neoplasms
A Phase 2 study of Metastatic Neoplasm and Metastatic Neoplasm to the Spine, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 240
- Enrollment target
- 2
- Study locations
NCT05617716 is a Phase 2 study of Metastatic Neoplasm and Metastatic Neoplasm to the Spine that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 240 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT05617716, a Phase 2 study of Metastatic Neoplasm and Metastatic Neoplasm to the Spine, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 240 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to compare three types of radiation therapy for cancer that has spread to the spine. The two types of radiation therapy used in this trial are External Beam Radiation Therapy (EBRT) and Stereotactic Body Radiation Therapy (SBRT). EBRT delivers tightly targeted radiation beams from outside the body. SBRT is a specialized type of radiation therapy that allows high doses of radiation to small targets. This study will include standard dose SBRT and higher dose SBRT. Each participant will be randomly assigned to either EBRT, standard dose SBRT, or higher dose SBRT.
Conditions Studied
Interventions
- RADIATION Conventional external beam radiation therapy dose (EBRT)
- RADIATION Spine radiosurgery/stereotactic body radiation therapy standard dose
- RADIATION Spine radiosurgery/stereotactic body radiation therapy high dose
Study Locations (2)
Maryland
- Johns Hopkins University Hospitals - Baltimore
Oklahoma
- OU Health Stephenson Cancer Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2025-09-09 |
| Est. Completion | 2029-09-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05617716
The ClinicalTrials.gov registry entry for NCT05617716 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Metastatic Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Conventional external beam radiation therapy dose (EBRT) is the first listed.
NCT05617716 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05617716 about?
NCT05617716 is a clinical study titled "Spine Radiosurgery for Symptomatic Metastatic Neoplasms". The purpose of this study is to compare three types of radiation therapy for cancer that has spread to the spine. The two types of radiation therapy used in this trial are External Beam Radiation Therapy (EBRT) and Stereotactic Body Radiation Therapy (SBRT). EBRT delivers tightly targeted radiation ...
What is the current status of trial NCT05617716?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2025-09-09. Estimated completion is 2029-09-30.
What conditions does trial NCT05617716 study?
This clinical trial studies the following conditions: Metastatic Neoplasm, Metastatic Neoplasm to the Spine.
What interventions are being tested in trial NCT05617716?
The interventions under investigation include: Conventional external beam radiation therapy dose (EBRT) (RADIATION), Spine radiosurgery/stereotactic body radiation therapy standard dose (RADIATION), Spine radiosurgery/stereotactic body radiation therapy high dose (RADIATION).
Who is sponsoring clinical trial NCT05617716?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05617716 being conducted?
This trial has 2 study locations across Maryland, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.